세계의 트라실롤(아프로티닌) 시장 보고서(2025년) : 역학, 파이프라인 분석, 시장 인사이트 및 예측

Trasylol, the brand name for aprotinin, is a medication used to reduce bleeding and the need for transfusions during major surgeries, such as heart surgery. It works by inhibiting enzymes that break down blood clots, but it has been under scrutiny due to potential risks, including kidney dysfunction.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The primary types of trasylol (aprotinin) are natural aprotinin and recombinant aprotinin. Natural aprotinin is a protein extracted from bovine lungs, used to prevent excessive bleeding during surgery by inhibiting the breakdown of blood clots. It is distributed through hospital pharmacies, retail pharmacies, and online platforms for various medical procedures, including cardiac surgeries, orthopedic surgeries, and others.

The trasylol (aprotinin) market research report is one of a series of new reports from The Business Research Company that provides trasylol (aprotinin) market statistics, including trasylol (aprotinin) industry global market size, regional shares, competitors with a trasylol (aprotinin) market share, detailed trasylol (aprotinin) market segments, market trends and opportunities, and any further data you may need to thrive in the trasylol (aprotinin) industry. This trasylol (aprotinin) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry

The trasylol (aprotinin) market size is expected to see strong growth in the next few years. It will grow to $3,24,920 million in 2029 at a compound annual growth rate (CAGR) of 9%. The growth in the forecast period can be attributed to the rising prevalence of cardiovascular diseases, growing focus on advanced medical treatments, rising availability of genetic and diagnostic tests, rising prevalence of chronic disease, and increasing number of surgical procedures. Major trends in the forecast period include the adoption of high-end medical technologies and pharmaceuticals, the integration of tranexamic acid in clinical guidelines, the adoption of antifibrinolytic drugs in developing markets, emerging applications in sports medicine, and a focus on patient safety and personalized medicine.

The increasing number of surgical procedures is expected to drive the growth of the trasylol (aprotinin) market. The rise in chronic lifestyle diseases has led to more advancements in medical technology, making surgeries more effective and accessible. As a result, the demand for surgical procedures is on the rise. Trasylol, a protease inhibitor, was historically used during surgeries like coronary artery bypass grafting (CABG) to reduce blood loss and minimize the need for blood transfusions. For example, in December 2023, the UK Health Security Agency reported an increase in CABG surgeries, with 27,524 surgeries conducted in 2023. This growing volume of surgical procedures is likely to boost the demand for trasylol.

The growing incidence of bleeding disorders is key factor contributing to the growth of the trasylol market. Bleeding disorders, which impair the blood's ability to clot properly, can result in excessive bleeding. This rise can be attributed to factors such as improved diagnosis, increased awareness, and genetic and aging factors. Trasylol (aprotinin) is commonly used in surgical settings to prevent excessive blood loss in high-risk surgeries, such as cardiac surgery, by inhibiting fibrinolysis and stabilizing blood clots. In October 2022, the World Federation of Hemophilia reported 427,685 global cases of bleeding disorders, including hemophilia and von Willebrand disease. This growing incidence of bleeding disorders is expected to drive demand for Trasylol (aprotinin).

A key trend in the trasylol market is the exploration of inhaled aprotinin as a potential treatment for SARS-CoV-2 infections. This research focuses on repurposing aprotinin as a protease inhibitor in the treatment of COVID-19 when administered via inhalation. For example, in April 2022, Kent University in the UK and Goethe University in Germany partnered to study the use of aprotinin in treating COVID-19. Their research demonstrated that aprotinin could inhibit viral entry, and clinical trials showed positive outcomes, including reduced hospital stays. This collaboration underscores the potential for repurposing existing treatments like Trasylol for emerging health crises, which could expand the market further.

Key player operating in the trasylol (aprotinin) market is Bayer AG

North America was the largest region in the trasylol (aprotinin) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in trasylol (aprotinin) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the trasylol (aprotinin) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The trasylol market consists of sales of products including tranexamic acid, aminocaproic acid, generic aprotinin injections, and desmopressin. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Trasylol (Aprotinin) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on trasylol (aprotinin) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 10 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-4 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for trasylol (aprotinin) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The trasylol (aprotinin) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Natural Aprotinin; Recombinant Aprotinin
• 2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Platforms
• 3) By Application: Cardiac Surgeries; Orthopedic Surgeries; Other Medical Procedures
• Companies Mentioned: Bayer AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Trasylol (Aprotinin) Market Characteristics

3. Trasylol (Aprotinin) Market Biologic Drug Characteristics

• 3.1. Molecule Type
• 3.2. Route Of Administration (ROA)
• 3.3. Mechanism Of Action (MOA)
• 3.4. Safety And Efficacy

4. Trasylol (Aprotinin) Market Trends And Strategies

5. Trasylol (Aprotinin) Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

6. Global Trasylol (Aprotinin) Growth Analysis And Strategic Analysis Framework

• 6.1. Global Trasylol (Aprotinin) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 6.2. Analysis Of End Use Industries
• 6.3. Global Trasylol (Aprotinin) Market Growth Rate Analysis
• 6.4. Global Trasylol (Aprotinin) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 6.5. Global Trasylol (Aprotinin) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 6.6. Global Trasylol (Aprotinin) Total Addressable Market (TAM)

7. Global Trasylol (Aprotinin) Market Pricing Analysis & Forecasts

8. Trasylol (Aprotinin) Market Segmentation

• 8.1. Global Trasylol (Aprotinin) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Natural Aprotinin
• Recombinant Aprotinin
• 8.2. Global Trasylol (Aprotinin) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Platforms
• 8.3. Global Trasylol (Aprotinin) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cardiac Surgeries
• Orthopedic Surgeries
• Other Medical Procedures

9. Global Trasylol (Aprotinin) Market Epidemiology Of Clinical Indications

• 9.1. Drug Side Effects
• 9.2. Incidence And Prevalence of Clinical Indications

10. Trasylol (Aprotinin) Market Regional And Country Analysis

• 10.1. Global Trasylol (Aprotinin) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. Global Trasylol (Aprotinin) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Asia-Pacific Trasylol (Aprotinin) Market

• 11.1. Asia-Pacific Trasylol (Aprotinin) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Trasylol (Aprotinin) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Asia-Pacific Trasylol (Aprotinin) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Asia-Pacific Trasylol (Aprotinin) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. China Trasylol (Aprotinin) Market

• 12.1. China Trasylol (Aprotinin) Market Overview
• 12.2. China Trasylol (Aprotinin) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 12.3. China Trasylol (Aprotinin) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 12.4. China Trasylol (Aprotinin) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

13. India Trasylol (Aprotinin) Market

• 13.1. India Trasylol (Aprotinin) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. India Trasylol (Aprotinin) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. India Trasylol (Aprotinin) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. Japan Trasylol (Aprotinin) Market

• 14.1. Japan Trasylol (Aprotinin) Market Overview
• 14.2. Japan Trasylol (Aprotinin) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. Japan Trasylol (Aprotinin) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. Japan Trasylol (Aprotinin) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Australia Trasylol (Aprotinin) Market

• 15.1. Australia Trasylol (Aprotinin) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.2. Australia Trasylol (Aprotinin) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Australia Trasylol (Aprotinin) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. South Korea Trasylol (Aprotinin) Market

• 16.1. South Korea Trasylol (Aprotinin) Market Overview
• 16.2. South Korea Trasylol (Aprotinin) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. South Korea Trasylol (Aprotinin) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.4. South Korea Trasylol (Aprotinin) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Western Europe Trasylol (Aprotinin) Market

• 17.1. Western Europe Trasylol (Aprotinin) Market Overview
• 17.2. Western Europe Trasylol (Aprotinin) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Western Europe Trasylol (Aprotinin) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.4. Western Europe Trasylol (Aprotinin) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. UK Trasylol (Aprotinin) Market

• 18.1. UK Trasylol (Aprotinin) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. UK Trasylol (Aprotinin) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. UK Trasylol (Aprotinin) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Germany Trasylol (Aprotinin) Market

• 19.1. Germany Trasylol (Aprotinin) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Germany Trasylol (Aprotinin) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Germany Trasylol (Aprotinin) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. France Trasylol (Aprotinin) Market

• 20.1. France Trasylol (Aprotinin) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. France Trasylol (Aprotinin) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. France Trasylol (Aprotinin) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Trasylol (Aprotinin) Market

• 21.1. Eastern Europe Trasylol (Aprotinin) Market Overview
• 21.2. Eastern Europe Trasylol (Aprotinin) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Trasylol (Aprotinin) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Trasylol (Aprotinin) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. North America Trasylol (Aprotinin) Market

• 22.1. North America Trasylol (Aprotinin) Market Overview
• 22.2. North America Trasylol (Aprotinin) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. North America Trasylol (Aprotinin) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.4. North America Trasylol (Aprotinin) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. USA Trasylol (Aprotinin) Market

• 23.1. USA Trasylol (Aprotinin) Market Overview
• 23.2. USA Trasylol (Aprotinin) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. USA Trasylol (Aprotinin) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. USA Trasylol (Aprotinin) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. Canada Trasylol (Aprotinin) Market

• 24.1. Canada Trasylol (Aprotinin) Market Overview
• 24.2. Canada Trasylol (Aprotinin) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. Canada Trasylol (Aprotinin) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. Canada Trasylol (Aprotinin) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. South America Trasylol (Aprotinin) Market

• 25.1. South America Trasylol (Aprotinin) Market Overview
• 25.2. South America Trasylol (Aprotinin) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. South America Trasylol (Aprotinin) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. South America Trasylol (Aprotinin) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. Middle East Trasylol (Aprotinin) Market

• 26.1. Middle East Trasylol (Aprotinin) Market Overview
• 26.2. Middle East Trasylol (Aprotinin) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. Middle East Trasylol (Aprotinin) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. Middle East Trasylol (Aprotinin) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Africa Trasylol (Aprotinin) Market

• 27.1. Africa Trasylol (Aprotinin) Market Overview
• 27.2. Africa Trasylol (Aprotinin) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Africa Trasylol (Aprotinin) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.4. Africa Trasylol (Aprotinin) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Trasylol (Aprotinin) Market Competitive Landscape And Company Profiles

• 28.1. Trasylol (Aprotinin) Market Competitive Landscape
• 28.2. Trasylol (Aprotinin) Market Company Profiles
  • 28.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 28.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 28.2.3. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
  • 28.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

29. Global Trasylol (Aprotinin) Market Pipeline Analysis

• 29.1. High Level Clinic Trail Information

30. Global Trasylol (Aprotinin) Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Trasylol (Aprotinin) Market

32. Recent Developments In The Trasylol (Aprotinin) Market

33. Trasylol (Aprotinin) Market High Potential Countries, Segments and Strategies

• 33.1 Trasylol (Aprotinin) Market In 2029 - Countries Offering Most New Opportunities
• 33.2 Trasylol (Aprotinin) Market In 2029 - Segments Offering Most New Opportunities
• 33.3 Trasylol (Aprotinin) Market In 2029 - Growth Strategies
  • 33.3.1 Market Trend Based Strategies
  • 33.3.2 Competitor Strategies

34. Appendix

• 34.1. Abbreviations
• 34.2. Currencies
• 34.3. Historic And Forecast Inflation Rates
• 34.4. Research Inquiries
• 34.5. The Business Research Company
• 34.6. Copyright And Disclaimer